Drug intelligence / Profile preview

Siji Antiviral Mixture

Development stage
Phase 4
Lead developer
Shaanxi Haitian Pharmaceutical
Administration
Oral
01

Overview

Siji Antiviral Mixture is a traditional Chinese medicine preparation used for its anti-inflammatory, antipyretic, and antiviral properties. [2, 3, 5] It is an approved over-the-counter medicine in China indicated for the treatment of upper respiratory tract infections, viral colds, and influenza, characterized by symptoms such as headache, fever, runny nose, and cough. [2, 11] The formula is a combination of eleven herbs: Houttuynia cordata, Platycodon grandiflorus, Morus alba leaf, Forsythia suspensa, Schizonepeta tenuifolia, Mentha haplocalyx, Perilla frutescens leaf, Prunus armeniaca seed, Phragmites communis rhizome, Chrysanthemum indicum flower, and Glycyrrhiza uralensis root. [2, 17] A clinical trial has evaluated its efficacy and safety in treating acute upper respiratory tract infections (common cold). [13, 19] Preclinical research suggests its mechanism of action may involve inhibiting the PERK/STAT3/NF-κB signaling pathway to reduce the inflammatory response and cellular stress caused by viral infections. [6, 8]

Brand names
Haitian Siji Antiviral Mixture
Other names
四季抗病毒合剂Siji Kangbingdu Heji
02

Targets

COXIL1B (Interleukin-1 beta)Mpro (3C-like proteinase of SARS-CoV-2)TNFA (Tumor necrosis factor alpha (soluble))NF-κBEIF2AK3 (Pkr-like endoplasmic reticulum kinase)STAT3 (Signal Transducer and Activator of Transcription 3)

Beyond the preview

Go deeper on Siji Antiviral Mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siji Antiviral Mixture.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call